Unfolded protein response signaling promotes myeloid cell production and cooperates with oncogenic mutation
Unfolded protein response (UPR) promotes protein homeostasis under endoplasmic reticulum stress. UPR signaling has numerous functions in metabolism, cancer, immunology, and neurodegenerative diseases. Recent studies also showed that UPR signaling has important roles in hematopoietic stem and progenitor cell biology. However, whether UPR signaling regulates hematopoietic lineage fate decision remains elusive. Here, we found that FcgR- MPP3 generates erythroid lineage and Jak2V617F mutation leads to overproduction of erythroid cells by expanding FcgR- MPP3. We showed that UPR signaling increases myeloid cell production through promoting FcgR- MPP3 transition to granulocyte/macrophage progenitor producing FcgR+ MPP3 at the expense of erythroid lineage via the XBP1 pathway. Under a disease condition, UPR signaling cooperates with Jak2V617F mutation and exacerbates disease phenotype in a mouse model of polycythemia vera (PV) through the ATF4 pathway. Activation of UPR signaling also increased myeloid output in healthy donor bone marrow MPP cells while skewing the output towards erythroid lineage in PV patient bone marrow MPP cells. Together, our results identify a novel function of UPR signaling in hematopoietic lineage specification and provide critical insights into targeting UPR signaling in hematological malignancies.
Authors
- Stephen T. Oh (ORCID: https://orcid.org/0000-0002-8564-5400)
- Shuyang Lin (ORCID: https://orcid.org/0000-0002-9522-7798)
- Hyojung Paik (ORCID: https://orcid.org/0000-0002-5803-0670)
- Hyunjoo Choi (ORCID: https://orcid.org/0000-0003-2843-0419)
- Maggie J. Cox
- Sang-Eun Jung
- Yoon-A Kang
- Yesenia Earth
- Jiye Yi (ORCID: https://orcid.org/0009-0002-3589-4334)
Institutions
- Washington University in St. Louis (US)
- Korea Institute of Science & Technology Information (KR)
- Korea University of Science and Technology (KR)
Publication Details
- Journal
- Blood Advances
- Published
- 2026-09-04
- DOI
- https://doi.org/10.1182/bloodadvances.2026019895
- Primary Topic
- Biochemical and Molecular Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American Cancer Society
- Bristol-Myers Squibb
- Leukemia Research Foundation
- Celgene
- Foundation for Barnes-Jewish Hospital
- Alvin J. Siteman Cancer Center
- CTI Biopharma
- Incyte
- Seoul National University
- Sierra Oncology
- National Institutes of Health
- National Cancer Institute
- Common Fund